Evidence map›Paper›PMID 41000027›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2025

First nationwide point-prevalence survey on healthcare-associated infections and antibiotic use in long-term care facilities, Switzerland, September 2024.

Domenica Flury, Emmanouil Glampedakis, Nando Bloch, Celine Gardiol, Fabian Grässli, Simone Kessler, Jacqueline Kuhn, Tanja Kurdovsky, Stefan P Kuster, Vanja Piezzi and 3 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Domenica FluryDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Health Ostschweiz, Cantonal Hospital of St. Gallen, University teaching and research hospital, St. Gallen, Switzerland.
Emmanouil GlampedakisCantonal Infection Prevention and Control Unit, Cantonal Doctor Office, Public Health Department of Canton Vaud, Lausanne, Switzerland.
Nando BlochDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Health Ostschweiz, Cantonal Hospital of St. Gallen, University teaching and research hospital, St. Gallen, Switzerland.
Celine GardiolFederal Office of Public Health, Bern, Switzerland.
Fabian GrässliDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Health Ostschweiz, Cantonal Hospital of St. Gallen, University teaching and research hospital, St. Gallen, Switzerland.
Simone KesslerDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Health Ostschweiz, Cantonal Hospital of St. Gallen, University teaching and research hospital, St. Gallen, Switzerland.
Jacqueline KuhnDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Health Ostschweiz, Cantonal Hospital of St. Gallen, University teaching and research hospital, St. Gallen, Switzerland.
Tanja KurdovskyFederal Office of Public Health, Bern, Switzerland.
Stefan P KusterDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Health Ostschweiz, Cantonal Hospital of St. Gallen, University teaching and research hospital, St. Gallen, Switzerland.
Vanja PiezziFederal Office of Public Health, Bern, Switzerland.
Matthias SchlegelDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Health Ostschweiz, Cantonal Hospital of St. Gallen, University teaching and research hospital, St. Gallen, Switzerland.
Simone ToppinoDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Health Ostschweiz, Cantonal Hospital of St. Gallen, University teaching and research hospital, St. Gallen, Switzerland.
Philipp KohlerEpidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

INTRODUCTIONData for healthcare-associated infections (HAI) and antibiotic use in long-term care facilities (LTCF) in Switzerland are lacking but are necessary to take actions.AIMWe aimed to estimate HAI prevalence and antibiotic use and to record existing structure and process indicators in the area of infection prevention/antibiotic use in Swiss LTCF.METHODSWe invited all Swiss LTCF for this PPS in September 2024 using the adapted Healthcare-Associated Infections in European Long-Term Care Facilities (HALT)-4 protocol. The proportion of residents with HAI and systemic antibiotic treatment was calculated for a representative sample, stratified by language region and size. We assessed resident-level and institutional risk factors for HAI in all participating institutions, using random-effects logistic regression.RESULTSWe included 94 LTCF (7,244 residents), whereof 49 LTCFs (3,375 residents) belonged to the representative sample. Median age of residents in the representative sample was 87 years (range: 36-107) and 2,334 (69.2%) were female. Prevalence of HAI was 2.2% (95% confidence interval (CI): 1.7-2.7); 2.7% (95% CI: 2.2-3.3) were receiving antibiotic treatment, with highest use in LTCF in French-speaking cantons (5.9%; 95% CI: 4.2-7.5). Urinary tract (46%) and respiratory infections (20%) were most common, aminopenicillins (26%) and nitrofurantoin (19%) the most commonly used antimicrobials. The strongest independent risk factor for HAI was presence of urinary catheters (adjusted odds ratio = 2.65; 95% CI: 1.71-4.11).DISCUSSIONPrevalence of HAI and antibiotic use in Swiss LTCFs were comparable to the European average from 2023/24. There are regional differences in antibiotic consumption. Urinary catheterisation, potentially modifiable, was the most important risk factor for HAI.

Indexed as

Anti-Bacterial AgentsCross InfectionLong-Term CareNursing HomesAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedPrevalenceRisk FactorsSurveys and QuestionnairesSwitzerlandUrinary Tract InfectionsAnti-Bacterial AgentsAntibiotic useHealthcare-associated infectionLong-term carePoint-prevalence surveySwitzerland

Identifiers

PMID41000027
PMCPMC12475890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.